Literature DB >> 712211

Excretion of porphyrins in urine and bile after the administration of delta-aminolevulinic acid.

Y Shimizu, S Ida, H Naruto, G Urata.   

Abstract

Excretion of porphyrins into bile and urine after intravenous injection of delta-ALA was studied in three patients with catheters inserted into the bile duct because of biliary obstruction and in two healthy volunteers. Excretion of porphyrins into bile increased in response to increasing doses of delta-ALA--up to 18 mumol/kg. On the other hand, excretion into urine reached a constant rate at 2 to 4 mumol/kg delta-ALA and did not increase further with larger doses. These findings suggest that transport of porphyrins across the liver cell membrane to the blood must be an important factor in determining the rate of excretion into the urine. After administration of delta-ALA,excretion of coproporphyrin III into urine increased more than that of coproporphyrin I. As a result, the former was the predominant form of urinary coproporphyrin. When radioactive delta-ALA was administered intravenously, far greater radioactivity was recovered in urine as coproporphyrin III than as coproporphyrin I. These results indicate that only a small portion of urinary coproporphyrin I is derived from the liver. A possible source of coproporphyrin I may be erythropoietic tissues, since the amount of urinary coproporphyrin I was considerably decreased in patients with severely suppressed erythropoiesis.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 712211

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  8 in total

Review 1.  Heme biosynthesis and the porphyrias.

Authors:  John D Phillips
Journal:  Mol Genet Metab       Date:  2019-04-22       Impact factor: 4.797

Review 2.  Environmental chemical exposures and disturbances of heme synthesis.

Authors:  W E Daniell; H L Stockbridge; R F Labbe; J S Woods; K E Anderson; D M Bissell; J R Bloomer; R D Ellefson; M R Moore; C A Pierach; W E Schreiber; A Tefferi; G M Franklin
Journal:  Environ Health Perspect       Date:  1997-02       Impact factor: 9.031

3.  Photosensitisation and photodynamic therapy of oesophageal, duodenal, and colorectal tumours using 5 aminolaevulinic acid induced protoporphyrin IX--a pilot study.

Authors:  J Regula; A J MacRobert; A Gorchein; G A Buonaccorsi; S M Thorpe; G M Spencer; A R Hatfield; S G Bown
Journal:  Gut       Date:  1995-01       Impact factor: 23.059

4.  The effects of ethanol, estrogen, and hexachlorobenzene on the activities of hepatic delta-aminolevulinate synthetase, delta-aminolevulinate dehydratase, and uroporphyrinogen decarboxylase in male rats.

Authors:  M Kondo; Y Shimizu
Journal:  Arch Toxicol       Date:  1986-10       Impact factor: 5.153

Review 5.  Protoporphyrin IX: the Good, the Bad, and the Ugly.

Authors:  Madhav Sachar; Karl E Anderson; Xiaochao Ma
Journal:  J Pharmacol Exp Ther       Date:  2015-11-20       Impact factor: 4.030

6.  PBPK Model of Coproporphyrin I: Evaluation of the Impact of SLCO1B1 Genotype, Ethnicity, and Sex on its Inter-Individual Variability.

Authors:  Hiroyuki Takita; Shelby Barnett; Yueping Zhang; Karelle Ménochet; Hong Shen; Kayode Ogungbenro; Aleksandra Galetin
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2021-01-19

7.  Efficacy of intravenous delta-aminolaevulinic acid photodynamic therapy on rabbit papillomas.

Authors:  L A Lofgren; A M Ronn; M Nouri; C J Lee; D Yoo; B M Steinberg
Journal:  Br J Cancer       Date:  1995-10       Impact factor: 7.640

8.  In vivo kinetics and spectra of 5-aminolaevulinic acid-induced fluorescence in an amelanotic melanoma of the hamster.

Authors:  C Abels; P Heil; M Dellian; G E Kuhnle; R Baumgartner; A E Goetz
Journal:  Br J Cancer       Date:  1994-11       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.